BEYFORTUS
BEYFORTUS
Approved
DIN Number
02537214
Drug Class
Human
Market Date
Nov 4, 2024
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02537214
AIG Number0164561001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BD08 NIRSEVIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification08:18.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
NIRSEVIMABActive
Strength: 100 MG / 1 ML
Monograph: NIRSEVIMAB